GGrantIndex
Sort

261,768 grants matching gene therapy

Epithelial Genes in Allergic Inflammation

$1,284,087
Gurjit K Khurana Hershey · Cincinnati Childrens Hosp Med Ctr · U19 · FY2024 · AI

Program Project in the Genetics of SLE

$1,283,940
University Of Alabama At Birmingham · P01 · FY2002 · AR

Gene Therapy Approaches for Primary Immunodeficiencies

$1,283,652
Fabio Candotti · National Human Genome Research Institute · Z01 · FY2008 · HG

Molecular diagnosis and outcome prediction in lymphoma

$1,283,581
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Oncogenic mechanisms and molecular targets in myeloma

$1,283,581
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Oncogenic mechanisms and molecular targets in lymphoma

$1,283,581
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

GENDER EFFECTS ON HIV BIOLOGY

$1,283,479
J. David Gladstone Institutes · P01 · FY2005 · HD

Clinical Genetics and Screening for Pulmonary Fibrosis

$1,283,458
Gary Matthew Hunninghake · Brigham And Women'S Hospital · R01 · FY2025 · HL

R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)

$1,283,450
James Wilson · University Of Pennsylvania · N01 · FY2015 · HL

Chromatin Remodeling and Gene Activation

$1,283,371
David J Clark · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD

Immune Reconstitution

$1,283,331
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

improving outcomes after stem cell transplantation

$1,283,329
Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Therapeutic evaluation in ovarian and breast cancer GEMGDA models

$1,283,220
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Preclinical GEM and GDA Models of Primary and Metastatic Melanoma

$1,283,220
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Treatment of Chemotherapy-Induced Peripheral Neuropathy via Genetic Repression of Sodium Channels

$1,283,183
Fernando Aleman Guillen · Navega Therapeutics, Inc. · R44 · FY2022 · CA

Enhancing immunity to malaria in young children with effective chemoprevention

$1,283,030
Prasanna Jagannathan · Stanford University · U01 · FY2021 · AI

Predictors of Progression in Barret's Esophagus

$1,283,007
Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA

Genetic Modifiers of Initiation and Progression of Mammary Cancer

$1,282,777
Kent W Hunter · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Understanding the mutational mechanism responsible for the Repeat Expansion Diseases

$1,282,698
Karen P. Usdin · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

The Monarch Initiative: Linking Diseases to Model Organism Resources

$1,282,691
Melissa A Haendel · Oregon State University · R24 · FY2019 · OD

Statistical Methods for Integrative Genomics in Cancer

$1,282,615
William James Gauderman · University Of Southern California · P01 · FY2024 · CA

Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis

$1,282,511
Douglas A Marchuk · Duke University · P01 · FY2016 · NS

Neurotology Program

$1,282,308
Wade Chien · National Institute On Deafness And Other Communication Disorders · ZIA · FY2018 · DC

Preclinical development of a novel therapeutic for Parkinson's disease

$1,282,299
Aarash Bordbar · Sinopia Biosciences, Inc. · R44 · FY2024 · NS

Decrypting Variants of Uncertain Significance in Long-QT Syndrome

$1,282,186
Alfred L George · Northwestern University At Chicago · R01 · FY2019 · HL